Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Stewart

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Bone Marrow Transplantation|August 5, 2000
Successful autologous bone marrow transplant without the use of blood product supportK K Ballen, P A Ford, H Waitkus, et al.
Human Gene Therapy|June 1, 1993
Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancerJ A O'Shaughnessy, K H Cowan, W Wilson, et al.
Cancer|May 15, 1994
Esthesioneuroblastoma. Long-term outcome and patterns of failure--the University of Virginia experienceB V Eden, R F Debo, J M Larner, et al.
Blood|June 1, 1995
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantationC E Dunbar, M Cottler-Fox, J A O'Shaughnessy, et al.
Human Gene Therapy|April 1, 1993
Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancerC E Dunbar, A W Nienhuis, F M Stewart, et al.
Transactions of the American Clinical and Climatological Association|May 28, 1998
Chiaroscuro hematopoietic stem cellP Quesenberry, M Habibian, M Dooner, et al.
Blood|August 9, 2001
Host marrow stem cell potential and engraftability at varying times after low-dose whole-body irradiationF M Stewart, S Zhong, J F Lambert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234N J Vogelzang, J E Herndon, A Miller, et al.
Transactions of the American Clinical and Climatological Association|January 1, 1985
Hemopoietic growth factor production by a marrow adherent cell lineP J Quesenberry, P D Witte, K Landreth, et al.
Kroc Foundation Series|January 1, 1984
Studies of the control of hemopoiesis in Dexter culturesP J Quesenberry, Z X Song, R J Gualtieri, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|August 5, 2000
Successful autologous bone marrow transplant without the use of blood product supportK K Ballen, P A Ford, H Waitkus, et al.
Human Gene Therapy|June 1, 1993
Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancerJ A O'Shaughnessy, K H Cowan, W Wilson, et al.
Cancer|May 15, 1994
Esthesioneuroblastoma. Long-term outcome and patterns of failure--the University of Virginia experienceB V Eden, R F Debo, J M Larner, et al.
Blood|June 1, 1995
Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantationC E Dunbar, M Cottler-Fox, J A O'Shaughnessy, et al.
Human Gene Therapy|April 1, 1993
Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancerC E Dunbar, A W Nienhuis, F M Stewart, et al.
Transactions of the American Clinical and Climatological Association|May 28, 1998
Chiaroscuro hematopoietic stem cellP Quesenberry, M Habibian, M Dooner, et al.
Blood|August 9, 2001
Host marrow stem cell potential and engraftability at varying times after low-dose whole-body irradiationF M Stewart, S Zhong, J F Lambert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234N J Vogelzang, J E Herndon, A Miller, et al.
Transactions of the American Clinical and Climatological Association|January 1, 1985
Hemopoietic growth factor production by a marrow adherent cell lineP J Quesenberry, P D Witte, K Landreth, et al.
Kroc Foundation Series|January 1, 1984
Studies of the control of hemopoiesis in Dexter culturesP J Quesenberry, Z X Song, R J Gualtieri, et al.
Pageof 10